NATURE BIOTECHNOLOGY

Scope & Guideline

Pioneering Innovations in Life Sciences

Introduction

Delve into the academic richness of NATURE BIOTECHNOLOGY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1087-0156
PublisherNATURE PORTFOLIO
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1989 to 2024
AbbreviationNAT BIOTECHNOL / Nat. Biotechnol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressHEIDELBERGER PLATZ 3, BERLIN 14197, GERMANY

Aims and Scopes

Nature Biotechnology focuses on the intersection of biological sciences and technology, emphasizing innovative methodologies and applications that advance our understanding and manipulation of biological systems for therapeutic and industrial purposes.
  1. Genome Editing and Engineering:
    A central theme in the journal is the exploration and advancement of genome editing technologies, particularly CRISPR and its derivatives. This includes the development of novel editing systems that enhance specificity and reduce off-target effects.
  2. Synthetic Biology:
    Nature Biotechnology publishes studies on synthetic biology, which involves designing and constructing new biological parts, devices, and systems. This encompasses the engineering of microbes for applications in medicine, agriculture, and environmental sustainability.
  3. Biotherapeutics and Drug Development:
    The journal frequently features research on the development of biotherapeutics, including monoclonal antibodies, CAR-T therapies, and RNA-based therapeutics. This area focuses on the translation of basic research into clinical applications.
  4. Bioinformatics and Computational Biology:
    Computational approaches to analyzing biological data are a major focus, with studies leveraging machine learning, deep learning, and other computational tools to interpret complex biological datasets.
  5. Microbiome Research:
    Research on the microbiome and its implications for health and disease is increasingly prominent, reflecting a growing interest in understanding host-microbe interactions and their therapeutic potential.
  6. Regenerative Medicine and Stem Cell Technology:
    The journal covers advancements in regenerative medicine, including the use of stem cells for tissue engineering and the development of new therapies for degenerative diseases.
Nature Biotechnology is currently witnessing several emerging themes that reflect the forefront of biotechnological research and innovation, highlighting the journal's adaptability to new scientific advancements.
  1. Advanced Genome Editing Techniques:
    Newly developed genome editing tools, such as prime editing and base editing, are gaining traction. These methods promise greater precision and fewer off-target effects, driving interest in their applications across various fields.
  2. Integration of AI in Biotechnology:
    The application of artificial intelligence and machine learning in biotechnology is rapidly expanding. Researchers are leveraging these technologies for predictive modeling, data analysis, and optimizing biotechnological processes.
  3. Personalized Medicine:
    Research focused on personalized medicine, particularly in the context of cancer and rare diseases, is on the rise. This trend is driven by advancements in genomics and an increasing emphasis on tailored therapeutic approaches.
  4. Sustainability and Environmental Biotechnology:
    There is an emerging focus on biotechnological solutions aimed at addressing environmental challenges, such as bioremediation and sustainable agricultural practices, reflecting a broader societal push towards sustainability.
  5. Cell and Gene Therapies:
    The field of cell and gene therapies is rapidly advancing, with increasing numbers of studies exploring novel therapies and delivery methods, particularly in the context of genetic disorders and cancer treatment.

Declining or Waning

While Nature Biotechnology continues to thrive in many areas, certain research themes have shown signs of waning interest or frequency in publication over recent years.
  1. Traditional Drug Discovery Methods:
    As biotechnology evolves, traditional methods of drug discovery, which rely heavily on high-throughput screening of small molecules, are becoming less prominent. The focus has shifted towards more innovative approaches, such as utilizing AI and machine learning for drug development.
  2. Plant Biotechnology:
    Although still relevant, the frequency of publications specifically focused on plant biotechnology has decreased as the field expands into more integrated approaches combining multiple disciplines such as synthetic biology and gene editing.
  3. Animal Models in Drug Testing:
    There appears to be a decline in studies centered around traditional animal models for drug testing, as researchers increasingly explore alternative methods, including organoids and in vitro systems that better mimic human physiology.
  4. Single-Cell Genomics:
    While single-cell genomics remains important, there is a noticeable shift towards more integrative approaches that combine single-cell data with spatial transcriptomics and proteomics, indicating a transition away from isolated single-cell studies.

Similar Journals

BIOTECHNOLOGY AND BIOENGINEERING

Unlocking Potential in Biotechnology and Bioengineering
Publisher: WILEYISSN: 0006-3592Frequency: 12 issues/year

BIOTECHNOLOGY AND BIOENGINEERING, published by Wiley, is a leading journal in the domains of applied microbiology, biotechnology, and bioengineering. With an ISSN of 0006-3592 and E-ISSN of 1097-0290, this journal has established itself as an essential resource for researchers, professionals, and students aiming to advance their knowledge and stay updated on cutting-edge innovations and methodologies in biotechnology. The journal has a commendable impact factor, and it is ranked in the second quartile (Q2) across multiple categories for 2023. This positions it favorably among its peers, underscoring its significance in the scientific community; for example, it ranks 23rd out of 127 in the field of Applied Microbiology and Biotechnology. As a hub of critical research findings and technological advancements, BIOTECHNOLOGY AND BIOENGINEERING invites contributions that push the boundaries of biotechnological applications, fostering a deeper understanding and development of sustainable solutions to current global challenges.

Cell Stem Cell

Transforming Knowledge into Innovation in Stem Cell Science
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

Regenerative Engineering and Translational Medicine

Driving Innovation at the Intersection of Science and Health
Publisher: SPRINGER HEIDELBERGISSN: 2364-4133Frequency: 4 issues/year

Regenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.

MOLECULAR BIOTECHNOLOGY

Advancing Knowledge in Applied Microbiology and Biotechnology
Publisher: SPRINGERNATUREISSN: 1073-6085Frequency: 12 issues/year

MOLECULAR BIOTECHNOLOGY, published by SPRINGERNATURE, is a pivotal journal in the fields of applied microbiology, molecular biology, biochemistry, and biotechnology. Since its inception in 1994, the journal has aimed to disseminate high-quality research that explores the intersection of molecular biology and technology, fostering advancements in biotechnology applications. With an ISSN of 1073-6085 and an E-ISSN of 1559-0305, it has established itself as a significant contributor to the scientific community, currently holding a Q3 ranking across multiple categories including Applied Microbiology & Biotechnology and Biochemistry in the 2023 metrics. Although not an open access publication, the journal remains accessible through various institutional subscriptions, providing valuable insights and findings to researchers and professionals. Given its ongoing commitment to quality and relevance, MOLECULAR BIOTECHNOLOGY serves as an essential resource for those involved in cutting-edge research and innovation in molecular biotechnology and related disciplines.

Cell Journal

Unlocking the Secrets of Life at the Cellular Level
Publisher: ROYAN INSTISSN: 2228-5806Frequency: 12 issues/year

Cell Journal is a leading interdisciplinary publication in the fields of Cell Biology, Developmental Biology, Molecular Biology, and Reproductive Medicine, published by ROYAN INST since its inception as an open-access journal in 2007. With an ISSN of 2228-5806 for print and 2228-5814 for electronic editions, it provides a vital platform for researchers and professionals to disseminate innovative findings and insights that shape our understanding of cellular processes and reproductive sciences. The journal boasts an impressive Scopus ranking, achieving a Q3 position in both Molecular Biology and Reproductive Medicine, highlighting its significance in the academic community. Situated in Tehran, Iran, Cell Journal encourages global collaboration through its accessible content, making cutting-edge research available to a diverse audience. As it converges from 2011 to 2024, the journal continues to emphasize the importance of thorough scientific inquiry, fostering advancements that drive both theoretical frameworks and practical applications in cell science.

Research Journal of Biotechnology

Exploring the frontiers of biotechnology research.
Publisher: RESEARCH JOURNAL BIOTECHNOLOGYISSN: 2278-4535Frequency: 12 issues/year

Research Journal of Biotechnology is a premier publication dedicated to advancing the field of biotechnology through the dissemination of impactful research articles. Published by Research Journal Biotechnology in India, this journal operates under an Open Access model, facilitating unrestricted access to high-quality research for researchers, professionals, and students worldwide. With an ISSN of 2278-4535 and an E-ISSN of 2278-4535, the journal aims to serve as a comprehensive platform for innovative studies in Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology. Despite its current Q4 quartile ranking in these categories, the journal aspires to extend its influence and visibility in the academic community, aiming for greater impact in the future. The journal features research articles that span a wide array of topics in biotechnology, fostering a collaborative and knowledge-rich environment for national and international scholars. We invite you to explore, contribute to, and engage with the expanding landscape of biotechnological research through the Research Journal of Biotechnology.

Biotechnology Journal

Pioneering research for a biotechnological future.
Publisher: WILEY-V C H VERLAG GMBHISSN: 1860-6768Frequency: 12 issues/year

Biotechnology Journal, published by WILEY-V C H VERLAG GMBH, stands at the forefront of biotechnological research and innovation, recognized for its significant contributions to the fields of applied microbiology, molecular medicine, and broader biotechnology. With its ISSN 1860-6768 and E-ISSN 1860-7314, this journal has achieved impressive 2023 quartile rankings, positioning itself in Q1 for both Applied Microbiology and Biotechnology and Medicine (miscellaneous), and Q2 in Molecular Medicine, showcasing its impact and relevance within the scientific community. Based in Germany, the journal aims to disseminate high-quality research that drives advancements in biotechnological applications, fostering a platform for researchers, professionals, and students to engage with cutting-edge developments. With its ongoing commitment to excellence, the Biotechnology Journal is an essential resource for those seeking to stay informed about the latest trends and innovations in biotechnology.

TRENDS IN BIOTECHNOLOGY

Driving Innovation at the Intersection of Biosciences and Technology
Publisher: CELL PRESSISSN: 0167-7799Frequency: 12 issues/year

TRENDS IN BIOTECHNOLOGY, published by CELL PRESS, stands as a premier journal since its inception in 1983, focusing on the dynamic and ever-evolving fields of bioengineering and biotechnology. With a notable impact factor and ranking in the top quartile (Q1) of its categories for 2023, this journal is recognized for its contribution to advancing scientific knowledge, boasting a Scopus rank of #5/311 in Biotechnology and #5/162 in Bioengineering, placing it in the 98th and 97th percentiles, respectively. Although it does not operate under an open access model, TRENDS IN BIOTECHNOLOGY ensures a rigorous peer-review process that provides a platform for high-quality research that influences both academic and industrial advancements. The journal's objectives encompass the dissemination of cutting-edge research findings, reviews, and insights that foster innovation in biotechnological applications, making it an invaluable resource for researchers, professionals, and students alike. With its broad scope across the intersection of biosciences and technology, TRENDS IN BIOTECHNOLOGY continues to lead discussions and developments that shape the future of the biotechnology landscape.

Bioengineered

Unlocking the Potential of Biotechnology
Publisher: TAYLOR & FRANCIS INCISSN: 2165-5979Frequency: 1 issue/year

Bioengineered, published by TAYLOR & FRANCIS INC, is an esteemed Open Access journal that has been at the forefront of research in the fields of bioengineering, biotechnology, and applied microbiology since its inception in 2012. With an impressive impact factor reflecting its high-quality contributions, the journal is categorized in the top quartiles, achieving Q1 rankings in Applied Microbiology and Biotechnology, as well as in Biotechnology and Medicine (Miscellaneous) for 2023. This active engagement in showcasing pioneering research is critical for professionals and students alike, facilitating access to revolutionary studies and methodologies. The journal operates under an Open Access model since 2018, ensuring that groundbreaking findings in bioengineering are readily accessible to a global audience. Situated in the United Kingdom, Bioengineered not only serves as a platform for innovative research but also underscores the importance of interdisciplinary collaborations among scientists, engineers, and biotechnologists.

International Journal of Stem Cells

Empowering Scientific Exploration in Cell Biology
Publisher: KOREAN SOC STEM CELL RESEARCHISSN: 2005-3606Frequency: 2 issues/year

The International Journal of Stem Cells is a distinguished peer-reviewed journal dedicated to advancing the field of stem cell research. Published by the Korean Society for Stem Cell Research, this journal has established itself as a vital source of high-quality research since its inception in 2008. Operating under the ISSN 2005-3606 and E-ISSN 2005-5447, the journal caters to a global audience, featuring works that span a diverse array of topics within Cell Biology and Developmental Biology. It is noteworthy that as of 2023, the journal is ranked Q3 in Cell Biology and Q2 in Developmental Biology, highlighting its growing influence and credibility in the scientific community. Given its commitment to facilitating open scientific communication, it is crucial for researchers, professionals, and students to engage with the rigorous research published in this journal as it profoundly impacts the understanding and application of stem cell science. With accessibility to a wealth of innovative studies, the International Journal of Stem Cells remains an indispensable resource for anyone interested in the transformative potential of stem cell research.